Young women are leading a worrying increase in early-onset type 2 diabetes diagnoses in England, according to a new analysis.
If a senior loses weight but also loses significant muscle mass, is the treatment really a success?” GLP-1s are meant for ...
Insulin resistance is one area under investigation. If you have been diagnosed with the condition, here’s how GLP-1s may help ...
Morning Overview on MSN
Ozempic-style drugs were not linked to a serious eye disease in people with diabetes
Millions of people with type 2 diabetes who take semaglutide, the active ingredient in Ozempic and Wegovy, can draw some ...
Diet soda is often considered a healthier alternative to regular soda because it's sugar-free and calorie-free. Choosing diet soda over regular soda can be an easy way to reduce intake of added sugars ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...
Rates of gestational and type 2 diabetes have increased alongside severe maternal morbidity during US delivery hospitalizations.
A trio of recent studies suggest that some people can keep the weight off.
A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...
Think Type 2 diabetes is just one disease? Cutting-edge research reveals it’s actually four — and thanks to machine learning, ...
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...
A large head-to-head analysis reveals when outcomes began to diverge and why questions about the drugs’ cardiovascular effects remain unresolved. Semaglutide vs. liraglutide and incidence of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results